The global adrenoleukodystrophy (ALD) drugs market was valued at US$ 519.4 Mn in 2024 and is projected to grow at a CAGR of 13.9% from 2025 to 2035, surpassing US$ 2.3 Bn by 2035. This growth is driven by improved diagnostic techniques, increased awareness of ALD, and advancements in gene therapy. https://www.transparencymarketresearch.com/adrenoleukodystrophy-drugs-market.html